Press Releases
 
Immune Checkpoint Inhibitors Market Size, Share and Growth, 2023

United States, 14 February 2018 -- Global immune checkpoint inhibitors market is expected to witness significant growth as these are proven to be more effective therapy in shrinking tumor in higher proportion of patients, as compared to other immunotherapies.

Immune checkpoint inhibitors are applicable to a wider range of tumor types such as advanced or metastatic non-small cell lung cancer, renal cancer and melanoma. These inhibitors lower the rate of severe toxicities and immune-mediated side-effects. These are also convenient to administer and yield a good response rate of any single-agent immunotherapy.

Get Report Sample at: https://www.psmarketresearch.com/market-analysis/immune-checkpoint-inhibitors-market/report-sample

The pharmaceutical companies are actively involved in the research and development of drug for immune checkpoint inhibitors. The pipeline of immune checkpoint inhibitors is rich with more than 50 drugs. In November 2016, Bristol-Myers Squibb Company and Infinity Pharmaceuticals collaborated to check the efficacy of combination of Opdivo (a PD-1 inhibitor monoclonal antibody) and IPI-549 (a phosphoinositide-3-kinase gamma inhibitor) in patients with advanced solid tumors.

Immune checkpoints comprised of cytotoxic T-lymphocyte antigen 4 (CTLA-4) inhibitors and PD-1 and PD-L1 inhibitors. CTLA-4 drug are molecules used to regulate, stimulate or inactivate the immune cells. PD-1 is found on the surface of cancer cells and it is used by tumors to evade the immune system; therefore, PD-1 inhibitor blocks PD-1 action and enables the body to attack and kill cancer cells. PD-L1 is a transmembrane protein of 40kDa that helps in suppressing the immune system during tissue allograft, pregnancy, autoimmune disease, hepatitis and other diseases.

Explore Report at: https://www.psmarketresearch.com/market-analysis/immune-checkpoint-inhibitors-market

Some of the key players operating in the global market are Merck & Co., Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Pfizer Inc., F. Hoffmann-La Roche AG, Novartis AG, Regeneron Pharmaceuticals, Inc., Ono Pharmaceutical Co., Ltd., and TG Therapeutics, Inc.

# # #


Submitted by Jacob, P&S Market Research on Wednesday, 14 February 2018 at 8:03 PM
Category: Health Care & Medical
 
Related News

Vacuum-assisted Fetal Delivery Systems Market – Latest Trends and Future Growth Study by 2025
Tuesday, 20 Feb 2018

Cell Line Authentication and Characterization Tests Market Future Opportunities 2025
Tuesday, 20 Feb 2018

Pheochromocytoma Market with Current Trends Analysis, 2017 - 2025
Tuesday, 20 Feb 2018

Pet Insurance Market Shares, Strategies and Forecast Worldwide, 2017 - 2025
Tuesday, 20 Feb 2018

Pneumonia Therapeutics Market Growth and Forecast 2017 - 2025
Tuesday, 20 Feb 2018

Related Events

2nd Int'l Congress on Clinical Trials in Oncology & Hemato-Oncology 2018
Monday, 19 Feb 2018

Cardiology at Cancun: Topics in Clinical Cardiology
Monday, 19 Feb 2018

6th Annual Primary Care Winter CME Conference
Monday, 19 Feb 2018

CAR-TCR Summit Europe 2018
Tuesday, 20 Feb 2018

World CNS Summit
Tuesday, 20 Feb 2018

Latest News

The Importance Of A Pen
Tuesday, 20 Feb 2018

Painters in Woodstock, GA Set Record Number of Services in Recent Months
Tuesday, 20 Feb 2018

Sex talk - Phone Sex Chat
Tuesday, 20 Feb 2018

In Vitro Fertilization (IVF) Devices and Consumables Market: Market Size, Driving Players and Indust
Tuesday, 20 Feb 2018

10 Characteristics of Helpful Quality Management Systems
Tuesday, 20 Feb 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Tuesday, 20 February 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • 2nd Int'l Congress on Clinical Trials in Oncology & Hemato-Oncology 2018
  • Cardiology at Cancun: Topics in Clinical Cardiology
  • Tax Wise Workshop
  • 6th Annual Primary Care Winter CME Conference
  • Free Supply Chain Improvement Seminars Sydney CBD

  • Latest Jobs
    Sorry, there are currently no entries posted here.